Talocrural Manipulation and Ankle Muscle Architecture

Bitlis Eren University

Status: Completed

Conditions: Stroke

Treatments: Other: Talocrural Joint Manipulation; Other: Placebo Talocrural Joint Manipulation

Study type: Interventional

Funder types: Other

Identifiers

NCT07264946

BEUFTR-10

Details and patient eligibility

About

The aim of this study is to investigate the effect of talocrural joint manipulation on the ankle muscle architecture in patients with stroke.

Full description

The study, utilizing a randomized crossover design, is planned to be conducted on a minimum of 26 patients with stroke who meet the inclusion and exclusion criteria. Patients included in the study will be randomly assigned to receive both placebo talocrural joint manipulation and talocrural joint manipulation interventions.

Enrollment: 36 patients

Sex: All

Ages: 45 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Six months or longer elapsed since the stroke,
2. A Mini-Mental State Examination score of 24 or higher,
3. Being between 45 and 75 years of age,
4. Having a Brunnstrom stage of 4 or above

Exclusion criteria

1. The presence of severe osteoarthritis in the lower extremity,
2. The presence of cancer or diabetic neuropathy,
3. The presence of vestibular disorder,
4. The presence of lower extremity ulceration or amputation,
5. Hemodynamic instability,
6. The presence of other neurological disorders (such as multiple sclerosis, Parkinson's disease),
7. Having experienced an acute lower extremity injury in the last six weeks,
8. History of lower extremity surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

36 participants in 2 patient groups, including a placebo group

Placebo Talocrural Joint Manipulation Group

Placebo Comparator group

Description:

In this group, patients will receive placebo talocrural joint manipulation. The application will be similar to that in the experimental group, however, hands will be positioned to avoid creating traction or manipulation force, and this position will be maintained for 20 seconds.

Treatment:

Other: Placebo Talocrural Joint Manipulation

Talocrural Joint Manipulation Group

Experimental group

Description:

In this group, talocrural joint manipulation will be applied. After positioning the patient, high velocity low amplitude traction will be applied.

Treatment:

Other: Talocrural Joint Manipulation